CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals (NYSE Alternext US: JAV) announced today that Martin J. Driscoll, CEO will present at J.P. Morgan’s 27th Annual Healthcare Conference at 11:30 a.m. PT on Thursday, January 15, 2009 at the Westin St. Francis Hotel in San Francisco, CA. Mr. Driscoll will provide a company overview and update on the status of Javelin’s clinical and commercialization activities.
